More patients with prostate cancer being treated appropriately based on risk
the ONA take:
According to a study published in JAMA earlier this month, researchers at University of California, San Francisco, have found that patients with prostate cancer are now more likely to receive medical care matched to risk level.
Previous research has shown that patients with low-risk prostate cancer have been overtreated for decades and inadequately managed when the disease becomes more aggressive.
Now, researchers have determined that 40% of men with low-risk prostate cancer diagnosed between 2010 and 2013 opted for active surveillance compared with only 10% of patients with low-risk disease diagnosed between 1990 and 2009. Researchers also found that rates of radiotherapy for patients with low-risk disease have declined since 1995.
"We expected to see a rise in surveillance rates, but were surprised by the steepness of the trajectory. It shows a major shift toward appropriate, risk-adapted management of the disease," said corresponding author Matthew Cooperberg, MD, MPH, associate professor in the departments of Urology and Epidemiology & Biostatistics at UCSF, and Helen Diller Family chair in Urology at the UCSF Helen Diller Family Comprehensive Cancer Center.
Patients with prostate cancer are now more likely to receive medical care matched to risk level.
Sign Up for Free e-newsletters
- Avoiding the ED: Planned Strategies for Unplanned Urgent Cancer Care
- NP-Led Clinics Improved Phase 1 Oncology Study Operations, Outcomes
- Art as Palliative Care: Bedside Intervention Improves Pain, Anxiety, Mood in Hospitalized Cancer Patients
- Unprotected Sex After Chemotherapy
- Mindfulness Training May Improve End-of-Life Conversations in Advanced Cancer
- Aligning Patient Goals With End of Life Treatment Decisions
- Study Suggests Greater Focus on the Needs of Family Caregivers of Patients With Cancer
- First Antibody-Based Treatment Regimen Approved for First-Line Treatment of Multiple Myeloma
- Increased Diabetes Risk Associated With Cancer Development
- Childhood Neuroblastoma Survivors at Risk for Psych Impairment
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|